Recovery of Motor Skills With the Use of Artificial Intelligence and Computer Vision
Launched by FEDERAL CENTER OF CEREBROVASCULAR PATHOLOGY AND STROKE, RUSSIAN FEDERATION MINISTRY OF HEALTH · Dec 26, 2023
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how new technology, specifically artificial intelligence and computer vision, can help people recover their movement skills after having a stroke. The goal is to see if these advanced tools can improve rehabilitation practices for patients who have experienced a stroke and are dealing with issues like reduced strength or muscle tightness in their arms.
To be eligible for the trial, participants should be between 65 and 74 years old and have had a recent stroke within the last six months that affects their arm movement. They should have some strength in their arm but still face challenges due to muscle tone problems. However, individuals with more severe impairments or certain other health issues, like severe pain or cognitive disorders, would not be eligible. Those who participate can expect to be involved in exercises that utilize the latest technology to help improve their motor skills, which could lead to better recovery outcomes in their daily lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Recent hemispheric stroke (ischemic or hemorrhagic):
- • Rankin scale: 3
- • Within 6 months post stroke.
- • Upper limb hemiparesis with strength ≤3 points proximally.
- • Muscle tone rise (≤3 points) on Ashford scale.
- • Complex sensitivity preserved per neuro examination
- Exclusion Criteria:
- • Rankin scale of 4 points and higher.
- • 6 months or more after undergoing stroke.
- • Structural changes in the joints of the upper extremities that limit joint mobility (contractures, ankylosis, metal structures that limit mobility).
- • Severe pain syndrome in the paretic upper limb at rest or when moving, preventing exercise (7 points or more on the scale).
- • Gross cognitive disorders, psychoemotional arousal, signs of hysteria, pseudobulbar syndrome (violent laughter, crying), aphasic disorders that prevent understanding of the task.
- • Visual disturbances that prevent the perception of information (neglect, hemianopia, myopia, diplopia).
- • Thrombosis of the veins in the upper and lower extremities without signs of recanalization, or arterial thrombosis.
- • Parkinsonism and other types of tremor.
About Federal Center Of Cerebrovascular Pathology And Stroke, Russian Federation Ministry Of Health
The Federal Center of Cerebrovascular Pathology and Stroke, under the auspices of the Russian Federation Ministry of Health, is a leading institution dedicated to advancing research and clinical practices in the field of cerebrovascular disorders and stroke management. As a prominent clinical trial sponsor, the center focuses on innovative therapies and preventive strategies to enhance patient outcomes and reduce the burden of cerebrovascular diseases. With a commitment to scientific excellence and collaboration, the center plays a pivotal role in shaping healthcare policies and improving treatment paradigms within the Russian healthcare system and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Michael Gorodnichev
Study Chair
Moscow Technical University of Communication and Informatics (MTUCI)
Galina Ivanova, Prof
Study Chair
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported